Beta Bionics, Inc. (BBNX) EPS (Basic) (2024 - 2026)

Beta Bionics (BBNX) has 3 years of EPS (Basic) data on file, last reported at -$0.49 in Q1 2026.

• Quarterly EPS (Basic) rose 6.61% year-over-year to -$0.49 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 (up 6.73% YoY) and the FY2025 annual result came in at -$1.5, up 76.92% from the prior year.
• EPS (Basic) fell to -$0.49 in Q1 2026 per BBNX's latest filing, from -$0.33 in the prior quarter.
• The five-year high for EPS (Basic) was -$0.33 in Q3 2025, with the low at -$1.9 in Q4 2024.
• Average EPS (Basic) over 3 years is -$0.96, with a median of -$0.53 recorded in 2025.
• Year-over-year, EPS (Basic) jumped 82.5% in 2025 and grew 6.61% in 2026.
• Beta Bionics' EPS (Basic) stood at -$1.9 in 2024, then jumped by 82.5% to -$0.33 in 2025, then sank by 48.3% to -$0.49 in 2026.
• Business Quant data shows BBNX's EPS (Basic) at -$0.49 in Q1 2026, -$0.33 in Q4 2025, and -$0.33 in Q3 2025.